Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnosis related groups (DRGs) still imperfect, but new system succeeding

This article was originally published in Clinica

Executive Summary

The DRG system is clearly beginning to work in Germany, but the DRG catalogue needs to be improved. So said the federal health ministry's DRG expert Dr Karl-Heinz Tuschen. Speaking at a MedInform/BVMed progress update conference, in Bonn on January 24, he said that the introductory transition phase (to 2009) will be most useful if the system progressively changes from a budget- to a prices-based system, and more services are fully integrated into the full DRGs. Transparency of the system has clearly improved.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel